Genetic variants as potential predictive biomarkers in advanced colorectal cancer patients treated with oxaliplatin-based chemotherapy-Reference-Cited by-同舟云学术

Genetic variants as potential predictive biomarkers in advanced colorectal cancer patients treated with oxaliplatin-based chemotherapy

Published:2017-05-23 Issue:3 Volume:233 Page:2193-2201
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Bahrami Afsane¹²,Amerizadeh Forouzan¹²,Hassanian Seyed Mahdi³⁴^ORCID,ShahidSales Soodabeh⁵,Khazaei Majid⁶,Maftouh Mina³,Ghayour-Mobarhan Majid³,Ferns Gordon A.⁷,Avan Amir³^ORCID

Affiliation:

1. Department of Modern Sciences and Technologies; Faculty of Medicine, Mashhad University of Medical Sciences; Mashhad Iran

2. Student Research Committee, Faculty of Medicine; Mashhad University of Medical Sciences; Mashhad Iran

3. Metabolic Syndrome Research Center; Mashhad University of Medical Sciences; Mashhad Iran

4. Department of Medical Biochemistry, Faculty of Medicine; Mashhad University of Medical Sciences; Mashhad Iran

5. Cancer Research Center; Mashhad University of Medical Sciences; Mashhad Iran

6. Department of Physiology, Faculty of Medicine; Mashhad University of Medical Sciences; Mashhad Iran

7. Brighton & Sussex Medical School; Division of Medical Education; Falmer Brighton, Sussex UK

Funder

Mashhad University of Medical Sciences

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Reference71 articles.

1. Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress;Bahrami;Journal of Cellular Biochemistry,2017

2. Targeting the RAS signaling pathway as a potential therapeutic target in the treatment of colorectal cancer;Bahrami;Journal of Cellular Physiology,2017

3. The therapeutic potential of targeting the BRAF in patients with colorectal cancer;Bahrami;Journal of Cellular Physiology,2017

4. Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress;Bahrami;Journal of Cellular Biochemistry,2017

5. Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients;Berretta;Annals of Oncology,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer;Scientific Reports;2023-03-16

2. Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer;Translational Oncology;2023-01

3. Platycodin D confers oxaliplatin Resistance in Colorectal Cancer by activating the LATS2/YAP1 axis of the hippo signaling pathway;Journal of Cancer;2023

4. Identification of KIF21B as a Biomarker for Colorectal Cancer and Associated with Poor Prognosis;Journal of Oncology;2022-11-21

5. Circ_0082182 upregulates the NFIB level via sponging miR-326 to promote oxaliplatin resistance and malignant progression of colorectal cancer cells;Molecular and Cellular Biochemistry;2022-10-11